JP2022507454A5 - - Google Patents
Info
- Publication number
- JP2022507454A5 JP2022507454A5 JP2021526394A JP2021526394A JP2022507454A5 JP 2022507454 A5 JP2022507454 A5 JP 2022507454A5 JP 2021526394 A JP2021526394 A JP 2021526394A JP 2021526394 A JP2021526394 A JP 2021526394A JP 2022507454 A5 JP2022507454 A5 JP 2022507454A5
- Authority
- JP
- Japan
- Prior art keywords
- fusosome
- cns
- cells
- target cell
- specific
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025075701A JP2025111747A (ja) | 2018-11-14 | 2025-04-30 | Cns送達のためのフソソーム組成物 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862767358P | 2018-11-14 | 2018-11-14 | |
| US62/767,358 | 2018-11-14 | ||
| US201962900064P | 2019-09-13 | 2019-09-13 | |
| US62/900,064 | 2019-09-13 | ||
| PCT/US2019/061424 WO2020102499A2 (en) | 2018-11-14 | 2019-11-14 | Fusosome compositions for cns delivery |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025075701A Division JP2025111747A (ja) | 2018-11-14 | 2025-04-30 | Cns送達のためのフソソーム組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022507454A JP2022507454A (ja) | 2022-01-18 |
| JP2022507454A5 true JP2022507454A5 (cg-RX-API-DMAC7.html) | 2022-11-22 |
| JP7676305B2 JP7676305B2 (ja) | 2025-05-14 |
Family
ID=68808599
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021526394A Active JP7676305B2 (ja) | 2018-11-14 | 2019-11-14 | Cns送達のためのフソソーム組成物 |
| JP2025075701A Pending JP2025111747A (ja) | 2018-11-14 | 2025-04-30 | Cns送達のためのフソソーム組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025075701A Pending JP2025111747A (ja) | 2018-11-14 | 2025-04-30 | Cns送達のためのフソソーム組成物 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20220008557A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3880179A2 (cg-RX-API-DMAC7.html) |
| JP (2) | JP7676305B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20210133948A (cg-RX-API-DMAC7.html) |
| CN (1) | CN113613633A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2019378881A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3120082A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL283179A (cg-RX-API-DMAC7.html) |
| SG (1) | SG11202105079QA (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020102499A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3235908A1 (en) | 2016-04-21 | 2017-10-25 | Ecole Normale Superieure De Lyon | Methods for selectively modulating the activity of distinct subtypes of cells |
| BR112019022539A2 (pt) | 2017-04-28 | 2020-06-16 | Agrospheres, Inc. | Composições e métodos para o encapsulamento e entrega escalonável de agorquímicos |
| US11624061B2 (en) | 2017-04-28 | 2023-04-11 | Agrospheres, Inc. | Compositions and methods for enzyme immobilization |
| BR112020005803A2 (pt) | 2017-09-25 | 2020-12-01 | Agrospheres, Inc. | composições e métodos para produção e administração moduláveis de produtos biológicos |
| CA3105953A1 (en) | 2018-07-09 | 2020-01-16 | Flagship Pioneering Innovations V, Inc. | Fusosome compositions and uses thereof |
| KR20210131991A (ko) | 2018-11-14 | 2021-11-03 | 플래그쉽 파이어니어링 이노베이션스 브이, 인크. | 구획-특이적 카고 전달을 위한 조성물 및 방법 |
| US12351837B2 (en) | 2019-01-23 | 2025-07-08 | The Broad Institute, Inc. | Supernegatively charged proteins and uses thereof |
| WO2020191241A1 (en) | 2019-03-19 | 2020-09-24 | The Broad Institute, Inc. | Methods and compositions for editing nucleotide sequences |
| WO2020214842A1 (en) | 2019-04-17 | 2020-10-22 | The Broad Institute, Inc. | Adenine base editors with reduced off-target effects |
| US20220259617A1 (en) | 2019-06-13 | 2022-08-18 | The General Hospital Corporation | Engineered human-endogenous virus-like particles and methods of use thereof for delivery to cells |
| EP4025698A1 (en) | 2019-09-03 | 2022-07-13 | Sana Biotechnology, Inc. | Cd24-associated particles and related methods and uses thereof |
| AU2021248815A1 (en) * | 2020-03-31 | 2022-10-13 | Flagship Pioneering Innovations V, Inc. | Targeted lipid particles and compositions and uses thereof |
| BR112023001272A2 (pt) | 2020-07-24 | 2023-04-04 | Massachusetts Gen Hospital | Partículas semelhantes a vírus aprimoradas e métodos de uso das mesmas para entrega às células |
| KR20230151513A (ko) | 2021-01-11 | 2023-11-01 | 사나 바이오테크놀로지, 인크. | Cd8 표적 바이러스 벡터의 용도 |
| JP2024532963A (ja) | 2021-04-08 | 2024-09-11 | サナ バイオテクノロジー,インコーポレイテッド | Cd8特異的抗体コンストラクト及びその組成物 |
| IL308836A (en) | 2021-05-28 | 2024-01-01 | Sana Biotechnology Inc | Lipid Particles Containing Baboon Truncated Endogenous Retrovirus (BAEV) Envelope Glycoprotein and Related Methods and Uses |
| EP4381081A1 (en) | 2021-08-04 | 2024-06-12 | Sana Biotechnology, Inc. | Use of cd4-targeted viral vectors |
| US20240398902A1 (en) * | 2021-09-13 | 2024-12-05 | Achelois Biopharma, Inc. | Multivalent interferon particles compositions and methods of use |
| EP4448775A1 (en) | 2021-12-17 | 2024-10-23 | Sana Biotechnology, Inc. | Modified paramyxoviridae attachment glycoproteins |
| US20250059239A1 (en) | 2021-12-17 | 2025-02-20 | Sana Biotechnology, Inc. | Modified paramyxoviridae fusion glycoproteins |
| WO2023150518A1 (en) | 2022-02-01 | 2023-08-10 | Sana Biotechnology, Inc. | Cd3-targeted lentiviral vectors and uses thereof |
| WO2023150647A1 (en) | 2022-02-02 | 2023-08-10 | Sana Biotechnology, Inc. | Methods of repeat dosing and administration of lipid particles or viral vectors and related systems and uses |
| WO2023193015A1 (en) | 2022-04-01 | 2023-10-05 | Sana Biotechnology, Inc. | Cytokine receptor agonist and viral vector combination therapies |
| WO2024044655A1 (en) | 2022-08-24 | 2024-02-29 | Sana Biotechnology, Inc. | Delivery of heterologous proteins |
| EP4590688A1 (en) | 2022-09-21 | 2025-07-30 | Sana Biotechnology, Inc. | Lipid particles comprising variant paramyxovirus attachment glycoproteins and uses thereof |
| EP4593805A2 (en) * | 2022-09-30 | 2025-08-06 | Turn Biotechnologies, Inc. | Arrdc1-mediated microvesicle-based delivery of therapeutic agents to cells and tissues of the eye |
| EP4602174A1 (en) | 2022-10-13 | 2025-08-20 | Sana Biotechnology, Inc. | Viral particles targeting hematopoietic stem cells |
| WO2024119157A1 (en) | 2022-12-02 | 2024-06-06 | Sana Biotechnology, Inc. | Lipid particles with cofusogens and methods of producing and using the same |
| WO2024220560A1 (en) | 2023-04-18 | 2024-10-24 | Sana Biotechnology, Inc. | Engineered protein g fusogens and related lipid particles and methods thereof |
| EP4698666A1 (en) | 2023-04-18 | 2026-02-25 | Sana Biotechnology, Inc. | Universal protein g fusogens and adapter systems thereof and related lipid particles and uses |
| AU2024274792A1 (en) | 2023-05-23 | 2025-10-23 | Sana Biotechnology, Inc. | Tandem fusogens and related lipid particles |
| WO2025184529A1 (en) | 2024-03-01 | 2025-09-04 | Sana Biotechnology, Inc. | Viral particles with fusogen display and related compositions and methods |
| WO2026032009A1 (en) * | 2024-08-06 | 2026-02-12 | Chinese Institute For Brain Research, Beijing (Cibr) | A microglia-specific regulatory element for aav-mediated transgene manipulation |
Family Cites Families (51)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL78703A (en) | 1985-05-10 | 1993-02-21 | Benzon Alfred | Method of producing extracellular enzymes, the enzymes produced thereby and compositions containing them; a hybrid plasmid and a dna fragment comprising dna encoding the enzymes; a microorganism harbouring the plasmid; and a method for removing nucleic acids from biological materials |
| US6534051B1 (en) * | 1992-11-20 | 2003-03-18 | University Of Medicine And Dentistry Of New Jersey | Cell type specific gene transfer using retroviral vectors containing antibody-envelope fusion proteins and wild-type envelope fusion proteins |
| WO1995023846A1 (en) * | 1994-03-04 | 1995-09-08 | University Of Medicine & Dentistry Of New Jersey | Cell-type specific gene transfer using retroviral vectors containing antibody-envelope and wild-type envelope-fusion proteins |
| US6013516A (en) | 1995-10-06 | 2000-01-11 | The Salk Institute For Biological Studies | Vector and method of use for nucleic acid delivery to non-dividing cells |
| WO1999032646A1 (en) | 1997-12-22 | 1999-07-01 | Oxford Biomedica (Uk) Limited | Equine infectious anaemia virus (eiav) based |
| PT904392E (pt) | 1996-10-17 | 2001-06-29 | Oxford Biomedica Ltd | Vectores retrovirais |
| JP2000514094A (ja) * | 1997-04-17 | 2000-10-24 | レオネ,パオラ | 脳への遺伝子治療のための送達システム |
| JPH10313865A (ja) * | 1997-05-15 | 1998-12-02 | Deinabetsuku Kenkyusho:Kk | ヒト補体制御因子が呈示されたベクター |
| WO1999013905A1 (en) | 1997-09-18 | 1999-03-25 | The Trustees Of The University Of Pennsylvania | Receptor-binding pocket mutants of influenza a virus hemagglutinin for use in targeted gene delivery |
| GB9720465D0 (en) | 1997-09-25 | 1997-11-26 | Oxford Biomedica Ltd | Dual-virus vectors |
| US5994136A (en) | 1997-12-12 | 1999-11-30 | Cell Genesys, Inc. | Method and means for producing high titer, safe, recombinant lentivirus vectors |
| JP2003532368A (ja) * | 1998-02-09 | 2003-11-05 | ジェンザイム・コーポレイション | 核酸デリバリービヒクル |
| GB9803351D0 (en) | 1998-02-17 | 1998-04-15 | Oxford Biomedica Ltd | Anti-viral vectors |
| FR2777909B1 (fr) | 1998-04-24 | 2002-08-02 | Pasteur Institut | Utilisation de sequences d'adn de structure triplex pour le tranfert de sequences de nucleotides dans des cellules, vecteurs recombinants contenant ces sequences triplex |
| AU2001244354A1 (en) * | 2000-03-30 | 2001-10-15 | Oxford Biomedica (Uk) Limited | Retinoic acid receptor beta-2, its antagonists, and gene therapy vectors for thetreatment of neurological disorders |
| GB0009760D0 (en) | 2000-04-19 | 2000-06-07 | Oxford Biomedica Ltd | Method |
| WO2002088346A2 (en) | 2001-05-01 | 2002-11-07 | National Research Council Of Canada | A system for inducible expression in eukaryotic cells |
| JP2005507927A (ja) * | 2001-10-30 | 2005-03-24 | バイオジェン・アイデック・エムエイ・インコーポレイテッド | パーキンソン病を処置するための方法および組成物 |
| US20040028687A1 (en) | 2002-01-15 | 2004-02-12 | Waelti Ernst Rudolf | Methods and compositions for the targeted delivery of therapeutic substances to specific cells and tissues |
| WO2003082200A2 (en) | 2002-03-27 | 2003-10-09 | Baylor College Of Medicine | Potent oncolytic herpes simplex virus for cancer therapy |
| EP1497437A4 (en) | 2002-05-01 | 2005-11-16 | Cell Genesys Inc | LENTIVIRAL VECTOR PARTICLES RESISTANT TO THE INACTIVATION OF A COMPLEMENT |
| EP1506287B1 (en) | 2002-05-14 | 2007-04-25 | Merck & Co., Inc. | Methods of adenovirus purification |
| EA008497B1 (ru) | 2002-11-21 | 2007-06-29 | Певион Биотех Лтд. | Высокоэффективные способные к слиянию везикулы, способ их получения и фармацевтическая композиция, их содержащая |
| WO2006027202A1 (en) | 2004-09-06 | 2006-03-16 | Unite De Recherche En Biotherapie Et Oncologie (Rubio) | Generation of multiparent cell hybrids |
| EP1828953B1 (en) | 2004-11-08 | 2013-03-06 | Yale University Corporation | Crystalline xpt guanine riboswitch from Bacillus subtilis and structure-based compound identification employing said riboswitch |
| EP1838856A4 (en) * | 2005-01-20 | 2010-07-14 | Agency Science Tech & Res | PROCESS FOR DELIVERING NUCLEIC ACIDS TO PERIPHERAL NEURONS |
| DK2002003T3 (en) * | 2005-05-27 | 2016-03-21 | Ospedale San Raffaele Srl | Gene vector comprising miRNA |
| WO2007099387A1 (en) | 2006-03-03 | 2007-09-07 | Mymetics Corporation | Virosome-like vesicles comprising gp41-derived antigens |
| WO2008071959A1 (en) * | 2006-12-12 | 2008-06-19 | Oxford Biomedica (Uk) Limited | Lentiviral vectors comprising micrornas |
| US20100040650A1 (en) * | 2008-05-30 | 2010-02-18 | Crowe Jr James E | Virus-Like paramyxovirus particles and vaccines |
| AU2008363813A1 (en) * | 2008-11-07 | 2010-05-14 | Children's Hospital Medical Center | Fusogenic properties of saposin C and related proteins and peptides for application to transmembrane drug delivery systems |
| US9050269B2 (en) | 2009-03-10 | 2015-06-09 | The Trustees Of The University Of Pennsylvania | Protection of virus particles from phagocytosis by expression of CD47 |
| WO2011058052A1 (en) * | 2009-11-13 | 2011-05-19 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Direct protein delivery with engineered microvesicles |
| WO2012156839A2 (en) | 2011-05-19 | 2012-11-22 | Ospedale San Raffaele S.R.L. | New generation of splice-less lentiviral vectors for safer gene therapy applications |
| DK2717922T3 (en) * | 2011-06-10 | 2019-01-07 | Bluebird Bio Inc | GENERATIVE VECTORS FOR ADDRENOLEUCODYSTROPHY AND ADDRENOMYELONE EUROPE |
| JP2013034401A (ja) * | 2011-08-04 | 2013-02-21 | Gunma Univ | アストロサイトで遺伝子を発現させるためのベクター |
| JP5372297B1 (ja) | 2012-12-20 | 2013-12-18 | 三菱電機株式会社 | 車載装置及びプログラム |
| US9108442B2 (en) | 2013-08-20 | 2015-08-18 | Ricoh Company, Ltd. | Image forming apparatus |
| GB201412494D0 (en) * | 2014-07-14 | 2014-08-27 | Ospedale San Raffaele And Fond Telethon | Vector production |
| WO2017004381A1 (en) * | 2015-06-30 | 2017-01-05 | St. Jude Children's Research Hospital, Inc. | Method for treating schizophrenia |
| CA2999279A1 (en) * | 2015-10-01 | 2017-04-06 | Goleini Inc. | Targeted expression of chloride channels and methods of use thereof |
| RU2761555C2 (ru) * | 2015-10-22 | 2021-12-09 | Джуно Терапьютикс Гмбх | Способы, наборы, средства и устройства для трансдукции |
| US20170112773A1 (en) | 2015-10-23 | 2017-04-27 | Board Of Regents, The University Of Texas System | Plasma membrane vesicles comprising functional transmembrane proteins |
| SG10201912763QA (en) * | 2015-11-05 | 2020-02-27 | Bamboo Therapeutics Inc | Modified friedreich ataxia genes and vectors for gene therapy |
| US11185555B2 (en) * | 2016-04-11 | 2021-11-30 | Noah James Harrison | Method to kill pathogenic microbes in a patient |
| EP3235908A1 (en) * | 2016-04-21 | 2017-10-25 | Ecole Normale Superieure De Lyon | Methods for selectively modulating the activity of distinct subtypes of cells |
| CA3030003A1 (en) * | 2016-07-08 | 2018-01-11 | F1 Oncology, Inc. | Methods and compositions for transducing lymphocytes and regulating the activity thereof |
| JP7483373B2 (ja) | 2016-07-29 | 2024-05-15 | ジュノー セラピューティクス インコーポレイテッド | 複製可能ウイルスの存在または非存在を評価するための方法 |
| CA3078096A1 (en) * | 2017-10-20 | 2018-10-19 | Genethon | Use of syncytin for targeting drug and gene delivery to regenerating muscle tissue |
| WO2019204666A1 (en) * | 2018-04-18 | 2019-10-24 | Oisin Biotechnologies, Inc. | Fusogenic lipid nanoparticles and methods for the manufacture and use thereof for the target cell-specific production of a therapeutic protein and for the treatment of a disease, condition, or disorder associated with a target cell |
| GB201807945D0 (en) * | 2018-05-16 | 2018-06-27 | Ospedale San Raffaele Srl | Vector production |
-
2019
- 2019-11-14 EP EP19817064.9A patent/EP3880179A2/en active Pending
- 2019-11-14 CN CN201980088528.XA patent/CN113613633A/zh active Pending
- 2019-11-14 SG SG11202105079QA patent/SG11202105079QA/en unknown
- 2019-11-14 US US17/293,842 patent/US20220008557A1/en active Pending
- 2019-11-14 CA CA3120082A patent/CA3120082A1/en active Pending
- 2019-11-14 JP JP2021526394A patent/JP7676305B2/ja active Active
- 2019-11-14 WO PCT/US2019/061424 patent/WO2020102499A2/en not_active Ceased
- 2019-11-14 AU AU2019378881A patent/AU2019378881A1/en active Pending
- 2019-11-14 KR KR1020217018175A patent/KR20210133948A/ko not_active Ceased
-
2021
- 2021-05-13 IL IL283179A patent/IL283179A/en unknown
-
2025
- 2025-04-30 JP JP2025075701A patent/JP2025111747A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025111747A5 (cg-RX-API-DMAC7.html) | ||
| US20240141381A1 (en) | Compositions and methods for treating phenylketonuria | |
| JP6634073B2 (ja) | リソソーム蓄積症処置用のアデノ随伴ウイルスベクター | |
| JP7838779B2 (ja) | フェニルケトン尿症を処置するための、プロモーターとエンハンサーの組み合わせを有するベクター | |
| US10323073B2 (en) | CRISPR-based methods and products for increasing frataxin levels and uses thereof | |
| JP6850736B2 (ja) | ムコ多糖症治療用のアデノ随伴ウイルスベクター | |
| US20230383270A1 (en) | Crispr/cas-based base editing composition for restoring dystrophin function | |
| IL282053B (en) | Recombinant glut1 adeno-associated viral vector constructs , compositions and kits comprising the same and use thereof | |
| Yang et al. | Systemic administration of AAV-Slc25a46 mitigates mitochondrial neuropathy in Slc25a46−/− mice | |
| CN117126829A (zh) | 基因构建体、表达载体、药物组合物及其用途 | |
| WO2017109039A1 (en) | Endothelium-specific nucleic acid regulatory elements and methods and use thereof | |
| US20240000914A1 (en) | Chicken anemia virus (cav)-based vectors | |
| US20250243496A1 (en) | Vector for generating a circular rna | |
| US20250270547A1 (en) | Trans-splicing ribozyme specific to apoe4 rna and use thereof | |
| US20210332368A1 (en) | Compositions and methods to restore paternal ube3a gene expression in human angelman syndrome | |
| KR20230003569A (ko) | Cdkl5 결핍 장애 (cdd)의 치료에 유용한 조성물 | |
| US20260139273A1 (en) | Synergistic Nucleic Acid Based Therapeutics and Methods of Use for Treating Genetic Disorders | |
| KR20230123925A (ko) | Neurod1 및 dlx2 벡터 | |
| BR112021003469A2 (pt) | genes sintéticos de feedback ativado, cassetes de seed match alvo e seus usos | |
| CN112566640A (zh) | 治疗精神分裂症和其他神经精神病症的方法 | |
| CN117018231B (zh) | 用于治疗神经病变的基因疗法及其应用 | |
| US20190111071A1 (en) | Method for promoting muscle regeneration | |
| US20240301408A1 (en) | Microrna 195 compositions and methods for treating cognitive impairment | |
| KR20230123926A (ko) | Dlx2 벡터 | |
| KR102315736B1 (ko) | Apoe4 rna 특이적 트랜스-스플라이싱 리보자임 및 이의 용도 |